The rise of Sildenafil initially drove a period of growth for major pharmaceutical companies, nevertheless recent changes present a uncertain picture for shareholders. Generic alternatives are eating into revenue, and https://umarwibn433129.theideasblog.com/41653367/viagra-and-the-pharmaceutical-industry-a-volatile-play